Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen Licenses Two Biomarkers for CDx Development

NEW YORK (GenomeWeb News) – Qiagen today announced two exclusive licensing deals aimed at developing companion diagnostic tests for glioblastoma, lymphoma, and other cancers.

In one deal, Qiagen has licensed an option on FGFR-TACC fusion genes from Columbia University. Qiagen plans to develop a diagnostic test based on the biomarker for doctors to use in identifying patients who may benefit from targeted treatments currently under development.

Qiagen also has an exclusive license option with the BC Cancer Agency, based in Vancouver, British Columbia, for the EZH2 Y641 mutation biomarker. Qiagen plans on developing a companion diagnostic based on that biomarker for selecting patients who would benefit from EZH2-targeted therapies being developed.

Financial and other terms of the deal were not disclosed.

"The expansion of our portfolio of biomarkers for the development of innovative companion diagnostics is a key focus of Qiagen," CEO Peer Schatz said in a statement. "Deep relationships with leading academic centers provide a rich source of biomarkers, as in these latest two agreements. In partnership with top pharmaceutical companies, we are translating genomic discoveries into standardized companion diagnostics to guide the use of targeted drugs."

In February, Qiagen and Eli Lilly inked a companion diagnostic agreement for the drug manufacturer's investigational and approved drugs across all therapeutic areas. Qiagen started the year with deals with Drug Response Dx, Insight Genetics, and InsermTransfert to expand its companion diagnostics development pipeline.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.